169 related articles for article (PubMed ID: 22902472)
21. In vivo electron spin resonance: An effective new tool for reactive oxygen species/reactive nitrogen species measurement.
Han JY; Hong JT; Oh KW
Arch Pharm Res; 2010 Sep; 33(9):1293-9. PubMed ID: 20945126
[TBL] [Abstract][Full Text] [Related]
22. Use of 3-acetoxymethoxycarbonyl-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl as an EPR oximetry probe: potential for in vivo measurement of tissue oxygenation in mouse brain.
Shen J; Liu S; Miyake M; Liu W; Pritchard A; Kao JP; Rosen GM; Tong Y; Liu KJ
Magn Reson Med; 2006 Jun; 55(6):1433-40. PubMed ID: 16680679
[TBL] [Abstract][Full Text] [Related]
23. Differences in pharmacokinetic behaviors of two lipophilic 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyl radicals, in vivo probes to assess the redox status in the brain using magnetic resonance techniques.
Takeshita K; Okazaki H; Tsukamoto M; Okazaki S
Magn Reson Med; 2021 Jan; 85(1):560-569. PubMed ID: 32905631
[TBL] [Abstract][Full Text] [Related]
24. Redox-sensitive regulation of macrophage-inducible nitric oxide synthase expression in vitro does not correlate with the failure of apocynin to prevent lung inflammation induced by endotoxin.
Viačková D; Pekarová M; Crhák T; Búcsaiová M; Matiašovic J; Lojek A; Kubala L
Immunobiology; 2011 Apr; 216(4):457-65. PubMed ID: 21093096
[TBL] [Abstract][Full Text] [Related]
25. Direct assessments of the antioxidant effects of propofol medium chain triglyceride/long chain triglyceride on the brain of stroke-prone spontaneously hypertensive rats using electron spin resonance spectroscopy.
Kobayashi K; Yoshino F; Takahashi SS; Todoki K; Maehata Y; Komatsu T; Yoshida K; Lee MC
Anesthesiology; 2008 Sep; 109(3):426-35. PubMed ID: 18719440
[TBL] [Abstract][Full Text] [Related]
26. Acetoxymethoxycarbonyl nitroxides as electron paramagnetic resonance proimaging agents to measure O2 levels in mouse brain: a pharmacokinetic and pharmacodynamic study.
Miyake M; Shen J; Liu S; Shi H; Liu W; Yuan Z; Pritchard A; Kao JP; Liu KJ; Rosen GM
J Pharmacol Exp Ther; 2006 Sep; 318(3):1187-93. PubMed ID: 16757536
[TBL] [Abstract][Full Text] [Related]
27. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.
Hyodo F; Matsumoto K; Matsumoto A; Mitchell JB; Krishna MC
Cancer Res; 2006 Oct; 66(20):9921-8. PubMed ID: 17047054
[TBL] [Abstract][Full Text] [Related]
28. Tissue redox activity as a sensing platform for imaging of cancer based on nitroxide redox cycle.
Zhelev Z; Aoki I; Gadjeva V; Nikolova B; Bakalova R; Saga T
Eur J Cancer; 2013 Apr; 49(6):1467-78. PubMed ID: 23265713
[TBL] [Abstract][Full Text] [Related]
29. Visualization of oxidative stress in ex vivo biopsies using electron paramagnetic resonance imaging.
Gustafsson H; Hallbeck M; Lindgren M; Kolbun N; Jonson M; Engström M; de Muinck E; Zachrisson H
Magn Reson Med; 2015 Apr; 73(4):1682-91. PubMed ID: 24753234
[TBL] [Abstract][Full Text] [Related]
30. In vivo evaluation of different alterations of redox status by studying pharmacokinetics of nitroxides using magnetic resonance techniques.
Bačić G; Pavićević A; Peyrot F
Redox Biol; 2016 Aug; 8():226-42. PubMed ID: 26827126
[TBL] [Abstract][Full Text] [Related]
31. Novel blood-brain barrier-permeable spin probe for in vivo electron paramagnetic resonance imaging.
Wang X; Emoto M; Miyake Y; Itto K; Xu S; Fujii H; Hirata H; Arimoto H
Bioorg Med Chem Lett; 2016 Oct; 26(20):4947-4949. PubMed ID: 27634198
[TBL] [Abstract][Full Text] [Related]
32. Development of nitroxide-based theranostic compounds that act both as anti-inflammatory drugs and brain redox imaging probes in MRI.
Emoto MC; Sato S; Fujii HG
Magn Reson Chem; 2016 Sep; 54(9):705-711. PubMed ID: 26990690
[TBL] [Abstract][Full Text] [Related]
33. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model.
Kuppusamy P; Afeworki M; Shankar RA; Coffin D; Krishna MC; Hahn SM; Mitchell JB; Zweier JL
Cancer Res; 1998 Apr; 58(7):1562-8. PubMed ID: 9537265
[TBL] [Abstract][Full Text] [Related]
34. Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent.
Hyodo F; Chuang KH; Goloshevsky AG; Sulima A; Griffiths GL; Mitchell JB; Koretsky AP; Krishna MC
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1165-74. PubMed ID: 18270519
[TBL] [Abstract][Full Text] [Related]
35. Brain contrasting ability of blood-brain-barrier-permeable nitroxyl contrast agents for magnetic resonance redox imaging.
Matsumoto K; Yamasaki T; Nakamura M; Ishikawa J; Ueno M; Nakanishi I; Sekita A; Ozawa Y; Kamada T; Aoki I; Yamada K
Magn Reson Med; 2016 Sep; 76(3):935-45. PubMed ID: 26414669
[TBL] [Abstract][Full Text] [Related]
36. EPR imaging to estimate the in vivo intracerebral reducing ability of mature rats after neonatal hypoxic-ischemic brain injury.
Yokoyama H; Ueda Y; Itoh O; Ikeda T; Noor JI; Ikenoue T
Magn Reson Imaging; 2004 Nov; 22(9):1305-9. PubMed ID: 15607103
[TBL] [Abstract][Full Text] [Related]
37. Characterization of in vivo tissue redox status, oxygenation, and formation of reactive oxygen species in postischemic myocardium.
Zhu X; Zuo L; Cardounel AJ; Zweier JL; He G
Antioxid Redox Signal; 2007 Apr; 9(4):447-55. PubMed ID: 17280486
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes.
Sano T; Umeda F; Hashimoto T; Nawata H; Utsumi H
Diabetologia; 1998 Nov; 41(11):1355-60. PubMed ID: 9833944
[TBL] [Abstract][Full Text] [Related]
39. Brain redox imaging.
Matsumoto K; Hyodo F; Anzai K; Utsumi H; Mitchell JB; Krishna MC
Methods Mol Biol; 2011; 711():397-419. PubMed ID: 21279614
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of lipophilically different 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyl radicals frequently used as redox probes in in vivo magnetic resonance studies.
Takeshita K; Okazaki S; Hirose Y
Free Radic Biol Med; 2016 Aug; 97():263-273. PubMed ID: 27302159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
